Missed our live webinar on case study ID11916? Catch up on demand! Discover how a poorly soluble drug was turned into a high-performing formulation in just six weeks, even with scarce API availability. Our experts, Fabrizio Fina and Zsolt Lendvai, present the fascinating case study of ID11916. They explain how they transformed its initial water-insoluble state into an innovative oral formulation, accelerating its path to the human clinical trial phase. Don't miss out on this insightful session! https://hubs.ly/Q02Kch-B0 #bioavailability #preformulation #earlyformulation #drugdevelopment
Evotec’s Post
More Relevant Posts
-
Missed our live webinar on case study ID11916? Catch up on demand! Discover how a poorly soluble drug was turned into a high-performing formulation in just six weeks, even with scarce API availability. Our experts, Fabrizio Fina and Zsolt Lendvai, present the fascinating case study of ID11916. They explain how they transformed its initial water-insoluble state into an innovative oral formulation, accelerating its path to the human clinical trial phase. Don't miss out on this insightful session! https://hubs.ly/Q02KcfNp0 #bioavailability #preformulation #earlyformulation #drugdevelopment
To view or add a comment, sign in
-
Missed our live webinar on case study ID11916? Catch up on demand! Discover how a poorly soluble drug was turned into a high-performing formulation in just six weeks, even with scarce API availability. Our experts, Fabrizio Fina and Zsolt Lendvai, present the fascinating case study of ID11916. They explain how they transformed its initial water-insoluble state into an innovative oral formulation, accelerating its path to the human clinical trial phase. Don't miss out on this insightful session! https://hubs.ly/Q02Kckpl0 #bioavailability #preformulation #earlyformulation #drugdevelopment
To view or add a comment, sign in
-
How to turn a poorly soluble drug into a high performing formulation in just six weeks with scarce API availability? Join our experts Fabrizio Fina and Zsolt Lendvai as they present the case study of ID11916 and explain how, from its initial water-insoluble state, it was quickly transformed into an innovative oral formulation, accelerating its path to the human clinical trial phase. Only two days to the webinar date! Learn more and register here- https://hubs.ly/Q02GzMT30 #bioavailability #preformulation #earlyformulation #drugdevelopment
To view or add a comment, sign in
-
How to turn a poorly soluble drug into a high performing formulation in just six weeks with scarce API availability? Join experts Fabrizio Fina and Zsolt Lendvai as they present the case study of ID11916 and explains how, from its initial water-insoluble state, it was quickly transformed into an innovative oral formulation, accelerating its path to the human clinical trial phase. Learn more and register here- https://hubs.ly/Q02z378q0 #bioavailability #preformulation #earlyformulation #drugdevelopment
To view or add a comment, sign in
-
VP Business Development at Evotec for contract API, drug product, preclinical development and integrated INDiGO IND packages inclusive of all three.
Learn about formulation development that can rescue a seemingly insoluble compound to be able to achieve necessary dosing for toxicology and for oral human use in the clinic.
How to turn a poorly soluble drug into a high performing formulation in just six weeks with scarce API availability? Join experts Fabrizio Fina and Zsolt Lendvai as they present the case study of ID11916 and explains how, from its initial water-insoluble state, it was quickly transformed into an innovative oral formulation, accelerating its path to the human clinical trial phase. Learn more and register here- https://hubs.ly/Q02z378q0 #bioavailability #preformulation #earlyformulation #drugdevelopment
To view or add a comment, sign in
-
Senior Formulation Scientist I | PhD in Pharmaceutics at UCL | Oral Formulations and 3D Printing Expert | Pharmacist
Webinar: Rescuing the Unsolvable – A Case Study Join me and my colleague Zsolt Lendvai on July 17th! We'll discuss how we turned a poorly soluble drug into a high-performing formulation in a short time and with scarce API availability. Looking forward to meeting you there and answering your questions! Learn more and register here: https://hubs.ly/Q02z4NDn0 #preformulation #earlyformulation #drugdevelopment #webinar #pharmaceuticals
How to turn a poorly soluble drug into a high performing formulation in just six weeks with scarce API availability? Join experts Fabrizio Fina and Zsolt Lendvai as they present the case study of ID11916 and explain how, from its initial water-insoluble state, it was quickly transformed into an innovative oral formulation, accelerating its path to the human clinical trial phase. Learn more and register here- https://hubs.ly/Q02z4NDn0 #bioavailability #preformulation #earlyformulation #drugdevelopment
To view or add a comment, sign in
-
How to turn a poorly soluble drug into a high performing formulation in just six weeks with scarce API availability? Join experts Fabrizio Fina and Zsolt Lendvai as they present the case study of ID11916 and explain how, from its initial water-insoluble state, it was quickly transformed into an innovative oral formulation, accelerating its path to the human clinical trial phase. Learn more and register here- https://hubs.ly/Q02z4NDn0 #bioavailability #preformulation #earlyformulation #drugdevelopment
To view or add a comment, sign in
-
Discover the "hard-rock" 😉 story of this compound in our new case study webinar with Fabrizio Fina, PhD and Zsolt Lendvai!
How to turn a poorly soluble drug into a high performing formulation in just six weeks with scarce API availability? Join experts Fabrizio Fina and Zsolt Lendvai as they present the case study of ID11916 and explain how, from its initial water-insoluble state, it was quickly transformed into an innovative oral formulation, accelerating its path to the human clinical trial phase. Learn more and register here- https://hubs.ly/Q02z4NDn0 #bioavailability #preformulation #earlyformulation #drugdevelopment
To view or add a comment, sign in
-
Multimodalities Drug Development Catalyst - SVP Pharmaceutical Development Science & Strategy at Evotec
🚀 Struggling with poorly soluble drugs? Learn how to transform them into high-performing formulations in just six weeks—even with limited API availability! Join experts Fabrizio Fina, PhD and Zsolt Lendvai on July 17th as they will walk you through their innovative approach, taking this water-insoluble drug to an effective oral formulation. Don't miss this opportunity to gain valuable insights from my passionate colleagues who are dedicated to finding the best solutions for your toughest compounds. Register now and accelerate your drug development journey! 👉 Learn more and register here: https://hubs.ly/Q02z4NDn0 #bioavailability #preformulation #earlyformulation #drugdevelopment #webinar #pharmaceuticals #innovation
How to turn a poorly soluble drug into a high performing formulation in just six weeks with scarce API availability? Join experts Fabrizio Fina and Zsolt Lendvai as they present the case study of ID11916 and explain how, from its initial water-insoluble state, it was quickly transformed into an innovative oral formulation, accelerating its path to the human clinical trial phase. Learn more and register here- https://hubs.ly/Q02z4NDn0 #bioavailability #preformulation #earlyformulation #drugdevelopment
To view or add a comment, sign in
-
VP Business Development at Evotec for contract API, drug product, preclinical development and integrated INDiGO IND packages inclusive of all three.
You've done lead optimization to find the right compound. You have demonstrated potency, selectivity and efficacy. There's just one problem. It isn't soluble enough to develop - you won't be able to achieve necessary concentrations in your tox studies and the formulation isn't suitable for the clinic. Please join us for a webinar where our experts present a real case study of developing a rescue formulation using minimal amounts of API.
How to turn a poorly soluble drug into a high performing formulation in just six weeks with scarce API availability? Join experts Fabrizio Fina and Zsolt Lendvai as they present the case study of ID11916 and explain how, from its initial water-insoluble state, it was quickly transformed into an innovative oral formulation, accelerating its path to the human clinical trial phase. Learn more and register here- https://hubs.ly/Q02z4NDn0 #bioavailability #preformulation #earlyformulation #drugdevelopment
To view or add a comment, sign in
92,888 followers